| Literature DB >> 33022970 |
V P Thinh Nguyen1,2, Jon Stewart2, Michel Lopez1, Irina Ioannou1, Florent Allais1,2.
Abstract
Glucosinolates (GSLs) are secondary plant metabolites abundantly found in plant order Brassicales. GSLs are constituted by an S-β-d-glucopyrano unit anomerically connected to O-sulfated (Z)-thiohydroximate moiety. The side-chain of the O-sulfate thiohydroximate moiety, which is derived from a different amino acid, contributes to the diversity of natural GSL, with more than 130 structures identified and validated to this day. Both the structural diversity of GSL and their biological implication in plants have been biochemically studied. Although chemical syntheses of GSL have been devised to give access to these secondary metabolites, direct extraction from biomass remains the conventional method to isolate natural GSL. While intact GSLs are biologically inactive, various products, including isothiocyanates, nitriles, epithionitriles, and cyanides obtained through their hydrolysis of GSLs, exhibit many different biological activities, among which several therapeutic benefits have been suggested. This article reviews natural occurrence, accessibility via chemical, synthetic biochemical pathways of GSL, and the current methodology of extraction, purification, and characterization. Structural information, including the most recent classification of GSL, and their stability and storage conditions will also be discussed. The biological perspective will also be explored to demonstrate the importance of these prominent metabolites.Entities:
Keywords: Brassicaceae family; Brassicales; Moringacea family; glucosinolates; myrosinases
Mesh:
Substances:
Year: 2020 PMID: 33022970 PMCID: PMC7582585 DOI: 10.3390/molecules25194537
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Hydrolysis of glucosinolate (GSL) by myrosinase (MYR) upon tissue disruption. (R = alkyl, aryl, indole).
Occurrence of GSL in plants of order Brassicales. GSL concentration is expressed as a minimum–maximum in µmol/g of dry material.
| Family | Species | Tissue | GSL Content | Reference |
|---|---|---|---|---|
|
|
| Seed | 15.8–19.4 | [ |
| Seed | 18.6–21.7 | |||
|
| Seed | 8.0–19.1 | ||
|
| Leaf | 0.6–6.9 | [ | |
| Seed | 10.8–57.9 | |||
| Seed | 35–170 | [ | ||
|
| Leaf | 4.3–129.9 | [ | |
| Seed | 15.7–127.6 | |||
| Leaf | 2.3–11.5 | [ | ||
| Floret | 8.2–19.5 | [ | ||
| Petiole | 0.5–31.7 | [ | ||
|
| Leaf | 17.3 | [ | |
| Seed | 39.4–81.3 | |||
|
| Leaf | 5.0–30.7 | [ | |
| Root | 1.0–145.5 | [ | ||
|
| Leaf | 4.7–217 | [ | |
| Seed | 112–354.4 | [ | ||
| Leaf | 33.9–59.4 | [ | ||
| Seed | 256–282 |
Figure 2Three separate phases of glucosinolate biosynthesis: R indicates the variable amino acid precursors, and R’ indicates either original or extended amino acid. The blue box indicates the chain elongation phase, the green box indicates the reconfiguration phase yielding the core structure of glucosinolate, and the red box indicates the glucosinolate side-chain modification phase of the glucosinolate core structure with some examples from Table 2. The figure was adapted from the biosynthesis of GSL proposed by Graser et al. [46].
Figure 3Conversion of Aldoximes to Thiohydroximic Acids. GSH: Glutathione.
Figure 4Retrosynthesis approach to GSL synthesis: anomeric disconnection (blue), hydroximate disconnection (red). OG: suitable protecting group.
Figure 5Synthesis of glucotropaeolin. OG represents a suitable protecting group.
Figure 6Synthesis of GSL following the aldoxime pathway (R, R’ = H, alkyl, or aryl).
Figure 7Synthesis of sinigrin employing nitronate pathway.
Figure 8Synthesis of glucobrassicin.
Classification of GSL structural examples validated by Blazevic et al. [4]. Index A, B, and C indicate aliphatic, aromatic, and indolic GSLs, respectively.
| No | Class | Index | Semi Systematic Name | Trivial Name | Characterization Methods | Reference |
|---|---|---|---|---|---|---|
| 1 | Ala | A | Methyl GSL | Glucocapparin | MS, NMR of GSL; MS of desGSL | [ |
| 2 | Val | A | 1-Methylethyl GSL | Glucoputranjivin | UV, IR, MS, NMR of GSL | [ |
| 3 | Val | A | (1 | Glucosisymbrin | MS, NMR of desGSL | [ |
| 4 | Val | B | (1 | Glucobenzosisymbrin | UV, IR of ITC | [ |
| 5 | Glu | A | 3-Carboxypropyl GSL | Deducted from ITC structure | [ | |
| 6 | Glu | A | 3-Methoxycarbonyl- propyl GSL | Glucoerypestrin | Partial NMR of GSL | [ |
| 7 | ? | A | Ethyl GSL | Glucolepidiin | Thiourea-type, IR compared to GSL structure | [ |
| 8 | ? | A | Thiourea-type method compared to GSL | [ | ||
| and MS from ITC | ||||||
| 9 | ? | A | MS of ITC | [ | ||
| 10 | ? | A | MS of ITC | [ | ||
| 11 | ? | A | 4-Oxoheptyl GSL | Glucocapangulin | Deducted from IR and 5-oxooctanoic acid | [ |
| 12 | ? | A | 5-Oxoheptyl GSL | Gluconorcappasalin | Thiourea-type, IR compared to GSL; | [ |
| MS from ITC | ||||||
| 13 | ? | A | 5-Oxooctyl GSL | Glucocappasalin | UV, IR of GSL and desGSL; partial NMR of desGSL | [ |
| 14 | ? | A | 4,5,6,7-Tetrahydroxydecyl GSL | UV, IR, NMR of ITC | [ | |
| 15 | ? | B | Phenyl GSL | MS of GSL | [ | |
| 16 | ? | B | 2-(4-Methoxyphenyl)-2,2-dimethyl ethyl GSL | IR, MS, NMR of ITC | [ | |
| 17 | Leu | A | 2-Methylpropyl GSL | MS, NMR of GSL and desGSL | [ | |
| 18 | Leu | A | 2-Hydroxy-2-methylpropyl | Glucoconringiin | MS, NMR | [ |
| 19 | Leu | A | 3-Methylbutyl GSL | MS of ITC | [ | |
| 20 | Leu | A | 3-Methylbut-3-eyl GSL | IR, MS, NMR of | [ | |
| ITC | ||||||
| 21 | Leu | A | 4-Methylpentyl GSL | MS of ITC | [ | |
| 22 | Ile | A | (1 | Glucocochlearin | MS, NMR of GSL and desGSL | [ |
| 23 | Ile | A | (1 | Glucosisaustricin | MS, NMR of desGSL | [ |
| 24 | Ile | B | (1 | Glucobenzsisaustricin | Thiourease-type, IR compared to GSL | [ |
| 25 | Ile | A | (2 | Glucojiaputin | UV, IR, MS, NMR of GSL and des GSL | [ |
| 26 | Ile | A | (2 | Glucocleomin | NMR of desGSL | [ |
| 27 | Ile | A | 3-Methylpentyl GSL | UV, IR, MS, NMR of GSL; MS, NMR of desGSL | [ | |
| 28 | Ile | A | 3-(Hydroxymethyl)pentyl GSL | NMR of GSL | [ | |
| 29 | Ile | A | 2-Hydroxy-3-methylpenyl GSL | MS, NMR of desGSL | [ | |
| 30 | Trp | C | 4-Methoxyindol-3-yl GSL | Glucorapassicin A | UV, IR, MS, NMR of synthesized GSL | [ |
| 31 | Trp | C | Indol-3-ymethyl GSL | Glucobrassicin | UV, IR, MS, NMR of GSL and desGSL | [ |
| 32 | Trp | C | 1-Hydroxyindol-3ylmethyl GSL | MS of GSL; UV, MS of desGSL | [ | |
| 33 | Trp | C | 4-Hydroxyindol-3-ylmethyl GSL | 4-Hydroxy-glucobrassicin | MS of GSL; UV, MS, NMR of desGSL | [ |
| 34 | Trp | C | 4-Methoxyindol-3-ylmethyl | 4-Methoxy-glucobrassicin | UV, MS, MS, NMR of GSL and desGSL | [ |
| 35 | Trp | C | 1-Methoxyindol-3-ylmethyl | Neoglucobrassicin | UV, IR MS, NMR of GSL; MS, NMR of desGSL | [ |
| 36 | Trp | C | 1,4-Dimethoxyindol-3-ymethyl | 1,4-Dimethoxy-glucobrassicin | UV, MS, NMR ofdesGSL | [ |
| 37 | Trp | C | 1-Acetylindol-3-ymethyl GSL | MS of desGSL | [ | |
| 38 | Trp | C | 1-Sulfoindol-3-ylmethyl GSL | UV, IR, MS, NMR of GSL | [ | |
| 39 | Trp | C | 6′-Isoferuloylindol-3-ylmethyl | 6′-Isoferuloyl-glucobrassicin | MS of GSL; UV, MS, NMR of desGSL | [ |
| 40 | Phe | B | Benzyl GSL | Glucotropaeolin | MS, NMR of GSL; UV, MS, NMR of desGSL | [ |
| 41 | Phe | B | 3-Hydroxybenzyl GSL | Glucolepigramin | MS of GSL; MS, NMR of desGSL | [ |
| 42 | Phe | B | 3-Methoxybenzyl GSL | Glucolimnanthin | MS, NMR of GSL; UV, MS, NMR of desGSL | [ |
| 43 | Phe/Trp | B | 4-Hydroxybenzyl GSL | Glucosinalbin | UV, MS, NMR of GSL and desGSL | [ |
| 44 | Phe/Trp | B | 4-Methoxybenzyl GSL | Glucoaubrietin | MS of GSL; UV, | [ |
| MS, NMR of | ||||||
| desGSL | ||||||
| 45 | Phe/Trp | B | 3,4-Dihydroxybenzyl GSL | Glucomatronalin | MS of GSL | [ |
| 46 | Phe/Tyr | B | 4-Hydroxy-3-methoxybenzyl | 3-Methoxysinalbin | UV, MS, NMR of desGSL | [ |
| 47 | Phe/Tyr | B | 3-Hydroxy-4-methoxybenzyl | Glucobretschneiderin | UV, IR, MS, NMR of GSL | [ |
| 48 | Phe/Tyr | B | 3,4-Dimethoxybenzyl GSL | UV, MS, NMR of | [ | |
| desGSL | ||||||
| 49 | Phe/Tyr | B | 4-Hydroxy-3,5-dimethoxybenzyl GSL | 3,5-Dimethoxy-sinalbin | UV, MS, NMR of desGSL | [ |
| 50 | Phe/Tyr | B | 3,4,5-Trimethoxybenzyl GSL | MS of GSL; UV, MS, NMR of desGSL | [ | |
| 51 | Phe | B | 2-Phenylethyl GSL | Gluconasturtiin | NMR of GSL; UV, MS, NMR of desGSL | [ |
| 52 | Phe | B | (2 | Glucobarbarin | MS, NMR of GSL and desGSL | [ |
| 53 | Phe | B | (2 | Epiglucobarbarin | MS, NMR of GSL and des GSL | [ |
| 54 | Phe | B | 2-(3-Hydroxy-phenyl)ethyl GSL | UV, MS, NMR of desGSL | [ | |
| 55 | Phe | B | 2-(4-Hydroxy-phenyl)ethyl GSL | Homosinalbin | MS, NMR of GSL; UV, MS, NMR of desGSL | [ |
| 56 | Phe | B | (2 | UV, MS, NMR of GSL and desGSL | [ | |
| (3-hydroxyphenyl)ethyl GSL | ||||||
| 57 | Phe | B | 3-Phenylpropyl GSL | MS of ITC | [ | |
| 58 | Phe | B | 4-Phenylbutyl GSL | MS of ITC | [ | |
| 59 | Phe | B | 5-Phenylpentyl GSL | Glucoarmoracin | MS of ITC | [ |
| 60 | Phe/Tyr | B | 2-(4-Methoxy-phenyl)ethyl GSL | NMR of GSL, MS, NMR of desGSL | [ | |
| 61 | Phe/Tyr | B | (2 | MS, NMR of GSL; UV, MS, NMR of desGSL | [ | |
| 62 | Phe/Tyr | B | (2 | UV, MS, NMR of desGSL | [ | |
| 63 | Phe/Tyr | B | (2 | MS, NMR of GSL | [ | |
| 64 | Phe | B | 2-( | MS of GSL and desGSL | [ | |
| 65 | Phe | B | 4-(4′- | 4-Acetyl-glucomoringin | MS of GSL and ITC | [ |
| 66 | Phe | B | 2-( | NMR of GSL | [ | |
| 67 | Phe | B | 6′-Isoferuloyl-2-phenylethyl GSL | 6′-Isoferuloyl-gluconasturtiin | MS of GSL, UV, MS NMR of desGSL | [ |
| 68 | Phe | B | 6′-Isoferuloyl-(2 | 6′-Isoferuloyl-epiglucobarbarin | MS, NMR of GSL; UV, MS, NMR of desGSL | [ |
| 69 | Phe | B | 6′-Isoferuloyl-(2 | 6′-Isoferuloyl-glucobarbarin | MS, NMR of GSL; UV, MS, NMR of desGSL | [ |
| 70 | Phe/Tyr | B | 6′-Isoferuloyl-( | MS of GSL; UV, MS NMR of desGSL | [ | |
| 71 | Phe/Tyr | B | 4-( | Glucomorinigin | MS, NMR of GSL and desGSL | [ |
| 72 | Met | A | 3-(Methylsulfanyl)propyl GSL | Glucoibervirin | MS, NMR of GSL | [ |
| 73 | Met | A | 4-Oxoheptyl GSL | Glucocapangulin | Deduction from IR, 5-oxooctanoic acid | [ |
| 74 | Met | A | 4-(Methylsulfanyl)butyl GSL | Glucoerucin | UV, IR, MS NMR of GSL | [ |
| 75 | Met | A | 5-(Methylsulfanyl)pentyl GSL | Glucoberteroin | UV, IR, MS, NMR of GSL; UV, MS, NMR of desGSL | [ |
| 76 | Met | A | 6-(Methylsulfanyl)heptyl GSL | UV, IR, MS, NMR of GSL | [ | |
| 77 | Met | A | 6-(Methylsulfanyl)hexyl GSL | Glucolesquerellin | UV, IR, MS, NMR of GSL | [ |
| 78 | Met | A | 8-(Methylsulfanyl)-3-oxooctyl GSL | MS of GSL; MS, NMR of des GSL | [ | |
| 79 | Met | A | 9-(Methylsulfanyl)nonyl GSL | MS of GSL | [ | |
| 80 | Met | A | 10 -(Methylsulfanyl)decyl GSL | MS of ITC | [ | |
| 81 | Met | A | 2-Methylsulfinylethyl GSL | UV, MS, NMR of | [ | |
| desGSL | ||||||
| 82 | Met | A | ( | Glucoiberin | MS, NMR, X-Ray of GSL; UV, MS, NMR of desGSL | [ |
| 83 | Met | A | ( | Glucoraphanin | MS, NMR of GSL, UV, MS NMR of desGSL | [ |
| 84 | Met | A | ( | Glucoalyssin | MS, NMR of GSL; MS of desGSL | [ |
| 85 | Met | A | ( | Glucohesperin | UV, IR, MS, NMR of GSL | [ |
| 86 | Met | A | ( | NMR of GSL; MS, NMR of desGSL | [ | |
| 87 | Met | A | ( | Glucohirsutin | UV, IR, MS, NMR of GSL; MS, NMR of desGSL | [ |
| 88 | Met | A | ( | Glucoarabin | UV, IR, MS, NMR of GSL; MS, NMR of desGSL | [ |
| 89 | Met | A | ( | Glucocamelinin | MS, NMR of GSL; MS of desGSL | [ |
| 90 | Met | A | ( | MS of GSL | [ | |
| 91 | Met | A | 3-(Methylsulfonyl)-propyl GSL | Glucocheirolin | MS of GSL; NMR of desGSL | [ |
| 92 | Met | A | 4-(Methylsulfonyl)butyl GSL | Glucoerysolin | MS of GSL; MS, NMR of desGSL | [ |
| 93 | Met | A | 6-(Methylsulfonyl)hexyl GSL | MS of GSL | [ | |
| 94 | Met | A | 8-(Methylsulfonyl)octyl GSL | UV, IR, MS, NMR of GSL; MS, NMR of desGSL | [ | |
| 95 | Met | A | 9-(Methylsulfonyl)nonyl GSL | UV, IR, MS, NMR of GSL; MS, NMR of desGSL | [ | |
| 96 | Met | A | 10-(Methylsulfonyl)decyl GSL | MS, NMR of desGSL | [ | |
| 97 | Met | A | (3 | IR, MS, NMR of GSL; NMR of desGSL | [ | |
| 98 | Met | A | ( | Glucoraphenin | MS, NMR of GSL; UV, NMR of desGSL | [ |
| 99 | Met | A | 3-Hydroxy-5-(methylsulfinyl)pentyl GSL | Deducted from tetrahydro-1,3-oxazine-2-thione | [ | |
| 100 | Met | A | 3-Hydroxy-5-(methylsulfony)pentyl GSL | UV, IR, MS, NMR of ITC | [ | |
| 101 | Met | A | 3-Hydroxy-6-(methylsulfanyl)hexyl GSL | Deducted from tetrahydro-1,3-oxazine-2-thione | [ | |
| 102 | Met | A | 3-Hydroxy-6-(methylsufinyl)hexyl GSL | Deducted from ITC | [ | |
| 103 | Met | A | 3-Hydroxy-5-(methylsulfinyl)pentyl GSL | Deducted from tetrahydro-1,3oxazine-2-thione and ITC | [ | |
| 104 | Met | A | 8-(Methylsulfanyl)-3-oxooctyl GSL | Deducted from ITC | [ | |
| 105 | Met | A | ( | Deducted from ITC | [ | |
| 106 | Met | A | 4-Mercaptobutyl GSL | MS, NMR of GSL | [ | |
| 107 | Met | A | ( | Glucorucolamine | MS, NMR of desGSL | [ |
| 108 | Met | A | Dimeric 4-mercaptobutyl GSL | MS, NMR of GSL; MS of desGSL | [ | |
| 109 | Met | A | 4-( | Diglucothiobeinin | MS of GSL; MS, NMR of desGSL | [ |
| 110 | Met | A | 6′-Benzoyl-4(methylsulfanyl)butyl GSL | 6′-Benzoyl-glucoerucin | UV, MS, NMR of desGSL | [ |
| 111 | Met | A | 6′-Benzoyl-4(methylsulfinyl)butyl- GSL | 6′-Benzoyl -glucopharanin | UV, MS, NMR of desGSL | [ |
| 112 | Met | A | ( | 6′-Sinapoyl-glucoraphenin | UV, IR, MS, NMR of desGSL | [ |
| 113 | Se-Met | A | 3-(Methylseleno)propyl GSL | Comparing MS with natural S-analog | [ | |
| 114 | Se-Met | A | 4-(Methylseleno)butyl GSL | Comparing MS with natural S-analog | [ | |
| 115 | Se-Met | A | 5-(Methylseleno)pentyl GSL | Comparing MS with natural S-analog | [ | |
| 116 | Met | A | Allyl glucosinolate | Sinigrin | MS, NMR, X-Ray of GSL; UV, MS, NMR of desGSL | [ |
| 117 | Met | A | But-3-enyl GSL | Gluconapin | MS, NMR of GSL; UV, MS, NMR of desGSL | [ |
| 118 | Met | A | Pent-4-enyl GSL | Glucobrassicanapin | MS of GSL; MS, NMR of desGSL | [ |
| 119 | Met | A | ( | Gluconapoleiferin | MS of GSL | [ |
| 120 | Met | A | ( | Progoitrin | MS, NMR of GSL; UV, MS, NMR of desGSL | [ |
| 121 | Met | A | ( | Epiprogoitrin | MS, NMR of GSL; UV, MS, NMR of desGSL | [ |
| 122 | Met | C | 2′,3′-Dihydro-2′-oxoindol-3′-ylacetate ester at 2-OH of ( | Glucoisatisin | UV, MS, NMR of GSL | [ |
| 123 | Met | C | 2′,3′-Dihydro-2′-oxoindol-3′-ylacetate of ester at 2-OH of ( | Epiglucoisatisin | UV, MS, NMR of GSL | [ |
| 124 | Met | C | 2′,3′-Dihydro-3′-hydroxy-2′-oxoindol-3′-ylacetate ester at 2-OH of ( | ( | UV, MS, NMR of GSL | [ |
| 125 | Met | C | 2′,3′-Dihydro-3′-hydroxy-2′-oxoindol-3′-ylacetate ester at 2-OH of ( | ( | UV, MS, NMR of GSL | [ |
| 126 | Met | B | ( | 2- | MS of desGSL | [ |
| 127 | Met | A | 2-Hydroxyethyl GSL | NMR of GSL | [ | |
| 128 | Met | A | 3-Hydroxypropyl GSL | MS, NMR of ITC | [ | |
| 129 | Met | A | 4-Hydroxylbutyl GSL | MS of GSL | [ | |
| 130 | Met | A | 3-Hydroxylbutyl GSL | Deducted from tetrahydro-1,3oxazine-2-thione | [ | |
| 131 | Met | B | 2-(Benzoyloxy)ethyl GSL | MS of GSL | [ | |
| 132 | Met | B | 3-(Benzoyloxy)propyl GSL | Glucomalcolmiin | MS of GSL; UV, MS of desGSL | [ |
| 133 | Met | B | 4-(Benzoyloxy)butyl GSL | MS of GSL; UV, MS, NMR of desGSL | [ | |
| 134 | Met | B | 5-(Benzoyloxy)pentyl GSL | MS, NMR of desGSL | [ | |
| 135 | Met | B | 6-(Benzoyloxy)hexyl GSL | Deducted from ITC | [ | |
| 136 | Met | B | 3-Sinapoyloxypropyl GSL | MS, NMR of desGSL | [ | |
| 137 | Met | B | 6′-Benzoyl-4-benzoyloxybutyl GSL | UV, MS, NMR of desGSL | [ |
desGSL: desfulfated Glucosinolates; IR: Infra-red; ITC: Isothiocyanates; MS: Mass Spectrometry; NMR: Nuclear Magnetic Resonance; Index: ?: Uncertain precursor.
Figure 9Overview of the active site of Sinapis alba Myrosinase showing interactions between residues and the 2-deoxy-2-fluoroglucosinolate (2FG) as substrate (Protein Data Bank accession number 1E70, resolution: 1.65 Å) [172]. Red dashed lines show hydrogen bonding interactions between the substrate and MYR residues within the active site. (a) Representation of the active site of Sinapis alba Myrosinase generated using PyMol. (b) Chemical structure representation of the MYR-2FG. (c) Structure of 2-deoxy-2-fluoroglucosinolate.
Figure 10Schematic reaction mechanism of MYR in the presence of ascorbic acid.
Figure 11Reconfiguration of unstable allylglucosinolate aglucone upon myrosinase-catalyzed hydrolysis. The black arrow pathway shows the formation of allylisothiocyanates employing spontaneous Lossen arrangement. The Blue arrow pathway shows the formation of allylthiocyanate assisted by protein specifier. The red arrow pathway indicates the formation of allylcyanide assisted by protein specifier. The figure was adapted from Eisenschmidt-Bönn et al. [179].